OptiLight, with optimal pulse technology (OPT), is the only intense pulsed light (IPL) device to receive approval from the United States Food and Drug Administration and to be listed by the Australian Therapeutic Goods Administration for the treatment of dry eye disease. This revolutionary technology uses broad spectrum IPL to break the vicious cycle of dry eye disease by alleviating abnormal blood vessels and rosacea; restoring meibomian glands; improving tear break-up time; reducing inflammatory mediators; restoring tear osmolarity to normal levels; and decreasing demodex mites and bacterial burden.
OptiLight boasts numerous proprietary features including OPT for stable, safe and repeatable energy delivery, along with SapphireCool technology, which provides the patient with greater comfort and protection along with faster results. The OPT hand-piece has been designed to fi t every delicate facial contour to get as close to the eye area as possible for even better results.
OptiLight treatments take around 15 minutes and around four treatments are recommended to complete a treatment plan.
Visit: www.lumenis.com.au
